Concurrent opioid prescribing by multiple providers is common in Medicare patients and is associated with higher rates of hospital admission related to opioid use, according to a study published last week in BMJ.
The National Association of Chain Drug Stores Retail Advisory Board will be heading to London on Feb. 25 to examine key marketplace trends, including multigenerational retailing, how the omni-channel is improving the shopping experience, urban retailing and managing OTC medications.
The market for electronic health and medical records is set to experience rapid growth over the coming years, with EMR peer group value estimated to climb from approximately $10.6 billion in 2012 to $17 billion by 2017, at a compound annual growth rate of 9.8%, according to research and consulting firm GlobalData.
The imminent entry of several companies — including big pharma, small biotech and generic participants — into the global biosimilars space will propel the market toward exponential growth. The market is expected to soar from $1.2 billion in 2013 to $24 billion in 2019, reported Frost & Sullivan in research released earlier this week.
Enchanted Life — a new, personal care e-commerce site where consumers can buy products, share beauty tips and learn about trends — is looking to meet the personal care needs of the multicultural community.
The hedge fund Elliott Management will attempt to block McKesson's offer to acquire the German pharmaceutical wholesaler Celesio because it “substantially undervalues” the company, according to a report in the New York Times published Tuesday.
Researchers at the University of Dundee and University College London on Wednesday reported that taking the maximum daily dose of some medicines would exceed the recommended daily limits for sodium, without any additional dietary intake, and potentially become an added risk factor for heart disease.
An experimental human papillomavirus vaccine made by Merck could offer a boost to the vaccine market, but the company will have to use effective marketing efforts to ensure uptake, according to a new study.
Procter & Gamble has announced that P&G Prestige has entered into a licensing agreement with Alexander McQueen to manufacture and sell designer fragrance products under the Alexander McQueen brand name.